Vir Biotechnology, Inc. (NASDAQ: VIR)
$7.5500
-0.0500 ( -0.66% ) 49.1K
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
Market Data
Open
$7.5500
Previous close
$7.6000
Volume
49.1K
Market cap
$1.04B
Day range
$7.5020 - $7.6950
52 week range
$7.1200 - $13.0900
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 15 | Nov 02, 2023 |
4 | Insider transactions | 1 | Oct 20, 2023 |
4 | Insider transactions | 1 | Oct 18, 2023 |
8-k | 8K-related | 12 | Oct 03, 2023 |
8-k | 8K-related | 12 | Sep 20, 2023 |
4 | Insider transactions | 2 | Sep 18, 2023 |
10-q | Quarterly Reports | 64 | Aug 04, 2023 |